Radiofrequency-Assisted Laparoscopic Partial Nephrectomy: Clinical and Histologic Results

Jonathan Coleman, Amar Singh, Peter A. Pinto, John L. Phillips, William F. Pritchard, Diane Wray‐Cahen, Bradford J. WoodJournal of Endourology 2007 · DOI

TL;DR

This study evaluates a novel radiofrequency (RF) device for minimally invasive partial nephrectomy (PN) in hereditary kidney cancer. The findings suggest the RF device provides effective hemostasis without the need for vascular clamping, preserving renal function and offering a promising alternative for complex cases.

What Problem Does This Paper Address?

Kidney-sparing surgery (NSS) is increasingly preferred over radical nephrectomy for small renal tumors, especially in patients with hereditary kidney cancer syndromes who often present with multiple, bilateral lesions. A major challenge in laparoscopic partial nephrectomy (LPN) has been managing blood loss and ensuring adequate hemostasis, often requiring temporary occlusion of the renal artery and vein (vascular occlusion or VO). This VO, even for short durations, can lead to renal ischemia and potential dysfunction. The paper addresses the need for a hemostatic tool that can facilitate LPN without VO, thereby minimizing the risk of renal injury and improving outcomes for these complex patient populations.

Methods

The study employed a two-pronged approach:

  • Clinical Series: Nineteen patients underwent 20 procedures (14 laparoscopic, 6 open) using a surface-conductive RF coagulation instrument (Tissuelink FB3.0). Data collected included operative time, blood loss, length of stay, complications, and surgical margin status. Renal function was assessed via serum creatinine levels.
  • Porcine Model: An acute porcine model was used to characterize the RF device's performance under controlled conditions. Lesions were created using the RF device, ultrasonic shears, and standard electrocautery. These lesions were analyzed for depth, diameter, and tissue viability (using tetrazolium-red staining) under both vascular perfusion (no VO) and vascular occlusion (VO) scenarios. Different treatment times and energy settings were explored.

The Tissuelink device works by applying RF energy to the tissue, creating a coagulative margin. A saline drip from the device tip helps dissipate heat and prevent carbonization. Lesions were then excised.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Hemostasis without Clamping: The RF device appears to provide effective hemostasis, enabling partial nephrectomy without the need for renal vascular clamping. This is a significant advancement for minimizing ischemic injury.
  • Preservation of Renal Function: Clinical results showed no significant change in serum creatinine levels post-surgery, suggesting that renal function was well-preserved despite the procedures.
  • Perfusion and Time Dependence: In the porcine model, the depth of RF coagulation is directly influenced by both the presence of blood flow (perfusion) and the duration of treatment. This highlights the importance of understanding these parameters for optimal use.
  • Comparison to Other Devices: The study briefly compares the RF device to ultrasonic shears and electrocautery in the porcine model, suggesting differences in lesion depth and characteristics.

Key Results

  • Clinical Outcomes: In 19 patients undergoing 20 procedures, 112 tumors were removed. Median operative time was 310 minutes, blood loss was 250 mL, and length of stay was 4 days. No positive surgical margins were reported. Pre- and post-operative creatinine levels were similar (1.0 mg/dL).
  • Porcine Model - Depth: In the porcine model, treatment depth was significantly less in the unclamped (perfused) model compared to the VO model (4.0 ± 1.7 mm vs. 7.0 ± 1.6 mm, P < 0.05). Lesion depth and diameter increased with treatment time.
  • Porcine Model - Viability: Viability depth correlated strongly with the depth of visible thermal lesions (Pearson correlation 0.989).
  • Complications: Three patients experienced postoperative complications, including an early urine leak, atrial fibrillation requiring anticoagulation, and a pulmonary embolus. These were managed conservatively.

Limitations and Future Work

  • Combined Groups: The clinical series combined open and laparoscopic procedures, which the authors acknowledge makes direct statistical comparison difficult due to potential selection bias.
  • Porcine vs. Human Tissue: Direct correlation between porcine and human tissue responses may be inaccurate.
  • Study Endpoints: The study did not formally assess treatment efficacy and safety as primary endpoints, but rather focused on hemostasis and lesion characteristics.
  • Future Work: The authors suggest further study on the device's use for obtaining additional surgical margin control, treating small surface lesions, or as an "insurance burn" on margins of questionable histology. The potential for greater depth than conventional electrocautery or harmonic coagulation warrants investigation.

Summary updated

Abstract

This RF energy device can provided adequate and uniform hemostatic control without hilar clamping during laparoscopic and open PN for hereditary renal tumors. Gross measures of renal function after surgery appeared clinically unchanged. Coagulation depth is dependent on both tissue perfusion and time in the porcine model.
BibTeX
@article{coleman2007radiofrequency,
  author = {Jonathan Coleman and Amar Singh and Peter A. Pinto and John L. Phillips and William F. Pritchard and Diane Wray‐Cahen and Bradford J. Wood},
  title = {{Radiofrequency-Assisted Laparoscopic Partial Nephrectomy: Clinical and Histologic Results}},
  journal = {Journal of Endourology},
  year = {2007},
  doi = {10.1089/end.2006.0223},
}
Figure